Table of contents
- New PMCPA constitution and complaints procedure
- Revised rules on prescribing information in advertisements
- Best practices which are now mandatory
Article summary
Life Sciences analysis: Jamie Hatzel, associate at Bristows, discusses the revisions brought by the Association of the British Pharmaceutical Industry’s (ABPI) 2024 Code of Practice, which will come into force on 1 January 2025, namely the new constitution and complaints procedure for the Prescription Medicines Code of Practice Authority (PMCPA), the revised rules regarding the inclusion of prescribing information in advertisements, and the upgrading of certain practices from ‘optional best practice’ to ‘mandatory’.
To continue reading this news article, as well as thousands of others like it, sign in with LexisNexis or register for a free trial
Access this content for free with a 7 day trial of LexisNexis and benefit from:
- Instant clarification on points of law
- Smart search
- Workflow tools
- 42 practice areas
Get your quote today and take step closer to being able to benefit from:
- Instant clarification on points of law
- Smart search
- Workflow tools
- 36 practice areas
Get a quote for Lexis+
* denotes a required field
CONTACT US
